Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Carbetocin for Prader-Willi Syndrome
NCT01968187Phase 2Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Jan 2014
- Primary completion
- Jul 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of carbetocin in Prader-Willi syndrome (PWS), sponsored by Ferring Pharmaceuticals. Started Jan 2014; status: completed.
02
Drugs
carbetocin
03
Conditions
Prader-Willi syndrome (PWS)
Beyond the preview
Go deeper on NCT01968187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01968187.